Recombinant Cytokeratin 19 抗体 (full length)
Our Local Distributor
北京 101111
Quick Overview for Recombinant Cytokeratin 19 抗体 (full length) (ABIN7878492)
抗原
See all Cytokeratin 19 (KRT19) 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
抗原表位
- full length
-
原理
- Recombinant KRT19 Antibody / Cytokeratin 19 (azide and preservative free)
-
纯化方法
- Protein A/G affinity
-
免疫原
- Recombinant full-length human KRT19 protein was used as the immunogen for the recombinant KRT19 antibody.
-
亚型
- IgG2b, kappa
-
-
-
-
应用备注
- Optimal dilution of the recombinant KRT19 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- -20 °C
-
储存方法
- Aliquot the recombinant KRT19 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
别名
- KRT19
-
背景
- Recognizes a protein of 40 kDa, identified as cytokeratin-19 (CK19), which is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.
-
UniProt
- P08727
抗原
-